Evidence map›Paper›PMID 35079599›Full record

ArticleOpen forum infectious diseases2022

Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant

Thomas P Lodise, Marc Scheetz, Joseph J Carreno, Henry Chambers, Vance Fowler, Thomas L Holland

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Protamine protects against vancomycin-induced kidney injury.Antimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Thomas P LodiseAlbany College of Pharmacy and Health Sciences, Albany, New York, USA.ORCID https://orcid.org/0000-0002-4730-0655
Marc ScheetzMidwestern University Chicago College of Pharmacy, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-1091-6130
Joseph J CarrenoAlbany College of Pharmacy and Health Sciences, Albany, New York, USA.ORCID https://orcid.org/0000-0001-9272-6973
Henry ChambersSan Francisco General Hospital, San Francisco, California, USA.
Vance FowlerDuke Clinical Research Institute, Durham, North Carolina, USA.
Thomas L HollandDuke Clinical Research Institute, Durham, North Carolina, USA.
Albany College of Pharmacy and Health Sciences · USClinical Research Institute · USMidwestern University · USSan Francisco General Hospital · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Quantifying renal injury among the most commonly used clinical antibiotic combinationsR21AI149026 · NIAID · MIDWESTERN UNIVERSITY · PI SCHEETZ, MARC HOWARD · 2020 to 2021
$413k
NIAID NIH HHS R21 AI149026NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

Among patients with methicillin-resistant

Indexed as

MRSAoutcomespharmacokineticsvancomycin

Identifiers

PMID35079599
PMCPMC8783632
OpenAlexW4207016330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.